| |
| |
|
| Insider
Information: |
Monia Brett P |
| Relationship: |
Director |
| City: |
Carlsbad |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
188,789 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$7,084,848 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
188,789 |
|
|
| Total
Value |
$7,084,848 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
9
|
|
Stock
price went up :
|
0
|
2
|
| Stock
price went down : |
0
|
7
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -81.6%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Ionis Pharmaceuticals Inc |
IONS |
CEO Level 15, Director |
2024-02-29 |
174,289 |
2012-01-01 |
0 |
Premium* |
|
|
Cognition Therapeutics Inc |
CGTX |
Director |
2024-06-07 |
14,500 |
2023-06-09 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
117 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 5
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| IONS |
Ionis Pharmaceuticals Inc |
Chief Executive Officer |
• • – |
2022-01-18 |
4 |
D |
$30.12 |
$593,786 |
D/D |
(19,714) |
80,230 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Drug Discovery |
• – – |
2014-07-01 |
4 |
A |
$30.20 |
$2,295 |
D/D |
76 |
1,892 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
CEO Level 15 |
• • – |
2023-08-31 |
4 |
A |
$30.56 |
$4,798 |
D/D |
157 |
121,881 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chief Executive Officer |
• • – |
2022-01-26 |
4 |
D |
$31.44 |
$252,526 |
D/D |
(8,032) |
88,396 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Drug Discovery |
• – – |
2014-07-31 |
4 |
AS |
$31.50 |
$2,489 |
D/D |
(79) |
1,813 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Drug Discovery |
• – – |
2013-09-19 |
4 |
AS |
$33.35 |
$1,679,700 |
D/D |
(50,000) |
769 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chief Executive Officer |
• • – |
2021-08-31 |
4 |
A |
$33.80 |
$11,998 |
D/D |
355 |
50,469 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
CEO Level 15 |
• • – |
2024-02-29 |
4 |
A |
$34.43 |
$18,521 |
D/D |
538 |
174,289 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chief Operating Officer |
• – – |
2018-07-01 |
4 |
A |
$35.42 |
$7,580 |
D/D |
214 |
15,997 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Drug Discovery |
• – – |
2013-09-20 |
4 |
AS |
$35.89 |
$656,105 |
D/D |
(18,281) |
769 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chief Operating Officer |
• – – |
2019-01-01 |
4 |
A |
$36.45 |
$7,654 |
D/D |
210 |
16,051 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chief Executive Officer |
• • – |
2022-04-01 |
4 |
AS |
$37.49 |
$13,309 |
D/D |
(355) |
88,662 |
0 |
% |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Drug Discovery |
• – – |
2014-08-26 |
4 |
AS |
$38.14 |
$1,043,010 |
D/D |
(27,344) |
1,813 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Drug Discovery |
• – – |
2014-01-02 |
4 |
AS |
$39.25 |
$14,210 |
D/D |
(362) |
486 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chief Executive Officer |
• • – |
2023-01-18 |
4 |
S |
$39.49 |
$989,947 |
D/D |
(25,066) |
120,863 |
0 |
% |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chief Executive Officer |
• • – |
2020-12-02 |
4 |
OE |
$39.87 |
$843,649 |
D/D |
21,160 |
50,039 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chief Executive Officer |
• • – |
2020-12-04 |
4 |
OE |
$39.87 |
$950,501 |
D/D |
23,840 |
52,719 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chief Executive Officer |
• • – |
2023-05-22 |
4 |
AS |
$40.13 |
$197,907 |
D/D |
(4,931) |
140,374 |
0 |
% |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Drug Discovery |
• – – |
2017-07-01 |
4 |
A |
$40.66 |
$6,627 |
D/D |
163 |
11,935 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chief Executive Officer |
• • – |
2023-02-06 |
4 |
S |
$40.69 |
$1,003,153 |
D/D |
(24,651) |
145,305 |
0 |
% |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Drug Discovery |
• – – |
2016-01-19 |
4 |
S |
$41.46 |
$91,541 |
D/D |
(2,208) |
7,693 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chief Executive Officer |
• • – |
2023-07-07 |
4 |
AS |
$42.25 |
$787,953 |
D/D |
(18,650) |
121,724 |
0 |
% |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Drug Discovery |
• – – |
2018-01-01 |
4 |
A |
$42.76 |
$6,670 |
D/D |
156 |
11,782 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chief Executive Officer |
• • – |
2020-02-29 |
4 |
A |
$43.16 |
$13,553 |
D/D |
314 |
28,957 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chief Executive Officer |
• • – |
2020-08-31 |
4 |
A |
$44.46 |
$10,491 |
D/D |
236 |
29,193 |
0 |
- |
|
117 Records found
|
|
Page 3 of 5 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
